1. Maternal Serum Ischemia Modified Albumin Level Does Not Change In The Presence of Intrauterine Growth Restriction.
- Author
-
Çetin, Orkun, Karaman, Erbil, Tolunay, Harun Egemen, Boza, Baris, Cim, Numan, Alisik, Murat, Erel, Ozcan, Şahin, Tuba Bozhüyük, Cetin, Ipek Dokurel, Yildizhan, Recep, and Şahin, Hanım Güler
- Subjects
FETAL growth retardation ,PREGNANCY complications ,ALBUMINS ,PREGNANT women ,FETAL development ,PLACENTA diseases - Abstract
Maternal vascular hypoperfusion is the most common cause of fetal growth restrict ion. Maternal oxidative status features are identifiable on placental pathology, and antepartum diagnostic methods are rapidly evolving. The current study was constructed to determine the maternal oxidative status by measuring serum ischemia modified albumin (IMA) levels in pregnancies complicated with idiopathic intrauterine growth restriction (IUGR). The current study was designed as a descriptive and cohort trial. A total of 87 pregnant women; 45 healthy controls and 42 pregnancies complicated with idiopathic IUGR were included to the study population. Maternal serum IMA concentration was measured prior to the administration of any medication. The perinatal outcomes of patie nts were also recorded. Maternal serum IMA concentration in pregnancies complicated by idiopathic IUGR was higher than in healthy controls. There was no significant difference between the groups (0.54±0.04 versus 0.55±0.06 ABSU, p: 0.314). IUGR is a significant pregnancy complication. Elevated oxidative stress which leads to an ischemic microenvironment is associated with IUGR. Maternal serum IMA which is a possible marker for oxidative stress is not increase in pregnancies complicated with idiopathic IUGR. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF